Pharming Group to participate in November investor conference

Rhea-AI Summary

Pharming Group has announced its participation in the Jefferies London Healthcare Conference 2024, scheduled for November 19-21 in London, U.K. CEO Sijmen de Vries will deliver a presentation on Wednesday, November 20 at 08:00 GMT/09:00 CET. The presentation will be accessible via live webcast, with a replay available in the 'Upcoming Events' and 'News' sections of Pharming's website. Interested parties can arrange one-to-one meetings with Pharming's management team by contacting their Investor Relations team or Jefferies representative.

Leiden, the Netherlands, November 5, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of November:

• Jefferies London Healthcare Conference 2024, London, U.K., November 19-21
  Sijmen de Vries, Chief Executive Officer, will present on Wednesday, November 20 at 08:00 GMT/09:00 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.

For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Jefferies representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, United Kingdom
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

• Pharming attending Investor Conferences November 2024_EN_05NOV24

FAQ

When is Pharming Group (PHARM) presenting at the Jefferies London Healthcare Conference 2024?

Pharming Group's CEO will present on Wednesday, November 20, 2024, at 08:00 GMT/09:00 CET.

How can investors watch Pharming Group's (PHARM) presentation at the Jefferies Conference?

Investors can watch the presentation via live webcast, and a replay will be available in the 'Upcoming Events' and 'News' sections of Pharming's website.

How can investors schedule meetings with Pharming Group (PHARM) management at the Jefferies Conference?

Investors can schedule one-to-one meetings by contacting Pharming's Investor Relations team at investor@pharming.com or through their Jefferies representative.